Bienvenue, visiteur de France
Connexion Changer de pays
  0 Articles
Rechercher:

2008 Proteomics Seminar Tour

Seminar Series Home

Register here


Agendas and Dates:
Mon Oct 6Tours
Tue Oct 7Utrecht
Wed Oct 8Copenhagen
Thu Oct 9Stockholm
Wed Oct 15Manchester
Thu Oct 16Dublin
Fri Oct 17London
Mon Oct 20 Vienna
Tue Oct 21Munich
Wed Oct 22 Basel
Thu Oct 23 Berlin
Mon Nov 10Madrid
Wed Nov 12 Barcelona
Thu Nov 13Milan

Abstracts
• Juan Casado-Vela
Applicability of LTQ-Orbitrap MS to address proteomic studies: high-throughput protein ID, changes of protein level using iTRAQ and de novo sequencing.

• Bruno Domon
Novel Strategies Enabling High-Throughput Proteomic Analyses

• Warwick Dunn
The role of the LTQ-Orbitrap in metabolic profiling of mammalian metabolomes

• Melanie Flint
Molecular determination of stress hormone-mediated drug resistance to Paclitaxel in breast cancer

• David Good
Characterizing the Human Embryonic Stem Cell Proteome ? Life with an ETD-Enabled Orbitrap

• Claus Jorgensen
Mapping of signaling networks in boundary formation by quantitative mass spectrometry and RNAi

• Patrick Kiefer
Metabolome analysis by liquid chromatography high resolution mass spectrometry using the LTQ-Orbitrap

• Bernhard Kuester
Robust iTRAQ peptide quantification on an LTQ-Orbitrap mass spectrometer and its application to chemical proteomics

• Martin Larsen
Phosphoproteomics ? technologies and application to the study of depolarization-dependent protein phosphorylation in nerve terminals

• Matthias Mann
Towards complete proteome quantitation

• Nick Morris
The use of phosphoproteomics to discover novel AMPK substrates

• Scott Peterman
Expediting targeted protein quantitation method development using a triple quadrupole mass spectrometer: software and hardware tools to address hypothesis-based and bioinformatics-based approaches.

• Douglas Phanstiel
Characterizing the Human Embryonic Stem Cell Proteome ? Life with an ETD-Enabled Orbitrap

• Maria Prieto (Spanish)
Análisis de Imagen por Espectrometría de Masas con el MALDI LTQ XL y MALDI LTQ Orbitrap: importancia de MS3 y del rango dinámico

• Sarah Robinson
Expediting targeted protein quantitation method development using a triple quadrupole mass spectrometer: software and hardware tools to address hypothesis-based and bioinformatics-based approaches

• John Rogers
Selective Enrichment and Quantitation of Phosphoproteins and Phosphopeptides Involved in Cell Proliferation

• Vladimir Shulaev
Metabolomics technology and bioinformatics.

• Carsten Sonksen
Full sequence and PTM characterization of recombinant proteins with analytic LC-Orbitrap MS/MS, software tools and what we still need.

• Kerstin Strupat
MALDI Produced Ions Inspected with a Linear Ion Trap - Orbitrap Mass Analyzer

• Peter Verhaert
Mass Spectrometry Imaging of Neuropeptides

• Rob Vreeken
Metabolomics and metabolite profiles for phenotyping of individuals.

• Wolfram Weckwerth
Genome-wide metabolomics, proteomics and data integration: from molecule to organism

• Amy Zumwalt
Early markers of kidney transplant rejection:
Proteomic workflows for discovery and the development of non-invasive, targeted quantitation assays









Proteomics 2008 - Rob Vreeken

Metabolomics and metabolite profiles for phenotyping of individuals.Application of Lipidomics

Rob J. Vreeken and Thomas Hankemeier1

1Netherlands Metabolomics Centre, Leiden University, Leiden, the Netherlands

Abstract
Metabolomics involves the comprehensive quantitative and qualitative analysis of all small molecules in cells, tissues, and body fluids. Metabolic processes are at the core of physiology. Consequently, metabolomics is ideally positioned to distinguish between health and disease. Comparing metabolic profiles of patients and healthy controls, including repeated measurements within patients, is a powerful novel tool to unravel the biochemical pathways involved in multi-factorial disorders and to determine the efficacy of pharmacological and/or nutritional interventions.
Differences in genetic background and/or environmental exposure among individuals are expected to give rise to differences in measurable characteristics, or phenotypes. The metabolome reflects many of the system properties and is therefore an important part of the phenotype. Lipids are a subclass of the metabolome and play an important role in physiology, as they have a wide range of functions. The systems-level analysis of lipids is also called lipidomics. Due to the complexicity of the composition of lipids, analysis of a wide range of lipids classes is complicated. We developed a method for lipid profiling and applied it to the phenotyping of healthy twins. Different Mass Spectrometric approaches, viz. full-scan as well as Selected Reaction Monitoring analysis using Quadrupole and Ion-Trap systems were used in a quantitative manner ands were evaluated.

The lipid profiling method comprised a reversed-phase liquid chromatography (RPLC)-MS method using electrospray ionization. An Ascentis Express C8 column (fused core particles) and a gradient comprising water, acetonitrile and isopropanol were used. Extraction of the blood sample was obtained using water, methanol and dichloromethane. The method was validated by adding non-endogenous lipids to the blood sample at different concentration levels. For the sample preparation it was investigated whether a normal-phase based lipid class separation prior to the RPLC-MS was improving the overall performance. Methods for the acquisition of MSn spectra using an LTQ Orbitrap were developed to investigate to which extent differences in the structures of lipids can be revealed by MSn spectra.